SOURCE: Solos Endoscopy, Inc.

June 22, 2006 08:31 ET

Solos Endoscopy, Inc. Retains Corporate Law Firm to Begin Uplisting to the NASDAQ Bulletin Board

BOSTON, MA -- (MARKET WIRE) -- June 22, 2006 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSE) is pleased to announce that the Company has taken the next step to uplist to the NASDAQ Bulletin Board or the American Exchange (AMEX), by retaining the corporate law firm, Lyne, Woodworth and Evarts LLP of Boston, Massachusetts.

Lyne, Woodworth & Evarts serves business organizations of many different sizes, assisting with corporate formation, capitalization, real estate, stockholder agreements, licensing matters, mergers, acquisitions, restructuring, and federal and state securities regulation. Their clients include closely held corporations, limited partnerships, limited liability companies, venture capitalists, entrepreneurs, family businesses, publicly held corporations and distributorships. Lyne, Woodworth & Evarts also counsels financial institutions, manufacturing companies, and service companies.

"We have recently achieved a number of significant milestones and we believe that we will attain many more in the coming months. This is a very large step for us in our goal to uplist to a higher exchange, such as the NASDAQ Bulletin Board or the AMEX. Lyne, Woodworth & Evarts is a very reputable law firm and we are pleased to work with professionals of their caliber," stated Robert Segersten, President of Solos Endoscopy, Inc.

Solos Endoscopy, Inc. recently announced that the Company has acquired early-stage cancer detection products from Lifeline Biotechnologies, which include the MastaScope™, First Warning System™, and OvaScope™.

About Lyne, Woodworth & Evarts LLP:

Lyne, Woodworth & Evarts has enjoyed a long and distinguished legacy of legal excellence. Since 1912, the Firm has been committed to serving the business and legal communities with zealous advocacy and the highest standards of professionalism. Their practice includes the four general areas of business and finance, commercial and civil litigation, real estate and commercial lending, and trusts and estates. Lyne, Woodworth & Evarts (www.lwelaw.com) offers their clients a richly diverse team of talented and skilled attorneys. Lyne, Woodworth & Evarts has been proudly serving many of the same clients for over fifty years.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • Contact:
    Big Apple Consulting USA, Inc. for Solos Endoscopy, Inc.
    Investor Relations
    1-866-THE-APPL(E)